Time is of the essence.... and OSL is lagging behind
Pancreatic cancer is notorious for low survival rates, but Dr Dean said new treatments in recent years had been a huge turning point.
“Patients with metastatic cancer used to be quoted a life expectancy of three or four months and now we are measuring survival in years,” he said.
https://au.news.yahoo.com/thewest/l...ctor-helps-woman-beat-pancreatic-cancer-odds/
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |